Vensana Capital — Full Portfolio

Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement.

BiotechGermantown, US

Mukul Jain(Executive Officer)FRFrancine R. Kaufman(Executive Officer, Director)inRSRick Sullivan(Executive Officer)inKenneth L Horton(Executive Officer)TTTimothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)in

Board seatPeter Justin Klein· per SEC Form D · $30M raise · filed Sep 2020

Co-investorsNENew Enterprise Associates (NEA)

SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation.

BiotechHealthtechMedical DevicesAliso Viejo, US

GSGlenn Sussman(Co-founder)inMYMalik Y. Kahook(Co-founder)inPMPatrick Mooney(CEO)

BoardJake Merrill(Director)GPGeoff Pardo(Director)BKBilal Khan(Director)

Co-investorsNENew Enterprise Associates (NEA)RARA CapitalSASamsara BioCapitalSASands Capital Ventures

Elucent develops precision-guided surgical technologies that use 3D spatial positioning to make surgical procedures less invasive and more effective.

Deep TechHardwareHealthtechMedical Devices

JPJason Pesterfield(President & Chief Executive Officer)in

Co-investorsRCRC Capital

Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function.

BiotechHealthtechMedical DevicesAtlanta, US

Dr. Murali Padala(Founder)DEDr. Eric Sarin(Founder, Director)Dr. Kirthana Suresh(Founder)Sai Muralidhar Padala(Executive Officer, Director)LCLori Chmura(CEO)inGowri Raman(Director)

Co-investorsBRBroadview VenturesEPEpidarex CapitalGRGRA Venture

Vensana Innovation is a venture-backed startup studio ("innovation engine") that launches and builds medical technology companies, providing capital along with technical, clinical, commercial, and business development support at all stages from ideation to commercialization.

Deep TechHealthtechMedical Devices

Ben(Co-founder)TTThomas Tu(CEO & Venture Partner)inBrian(Founding Member)Phil Marchand

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.

HealthtechMedical DevicesWayne, US

BJBruce J. Shook(President and CEO)MKMonica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)

Co-investorsNENew Enterprise Associates (NEA)GIGilde HealthcareLILightstone Ventures41415 Capital

Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).

BiotechHealthtechMedical DevicesAustin, US

Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)

BoardGPGeoff Pardo(Director)in

Board seatKNKirk NielsenMBMaria Berkman· per SEC Form D

Co-investorsBRBroadview VenturesRIRiverVest Venture PartnersTMTMC Venture FundCACadence Healthcare VenturesGIGilde HealthcareGIGilmartin Capital LLC+1 more

Artelon develops synthetic ligament and tendon reconstruction products based on its Dynamic Matrix technology for orthopedic soft tissue repair.

BiotechHealthtechMedical DevicesNew MaterialsMarietta, US

Lars Peterson(Founder)Aaron Smith(Executive Officer, Director)Mark Cohen(Director)Jeff Byrne(Executive Officer)Carter Meyer(Director)Steve Becker(Director)

Board seatKirk Nielsen· per SEC Form D

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

PFPaul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)

Board seatJKJustin Klein· per SEC Form D

Co-investorsADAdjuvant CapitalGLGlobal BrainMOMoore Venture PartnersNENew Enterprise Associates (NEA)WIWindham Capital PartnersDODomain Associates+2 more

Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.

AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US

JMJames Min, MD(Founder)inJKJames K. Min(Executive Officer, Director)in

BoardLee Cooper(Director)SBScott Barclay(Director)inLouis Samson(Director)

Board seatPeter Justin Klein· per SEC Form D

Co-investorsBABattery VenturesBRBreyer CapitalDIDigiTx Partners LLCINInsight PartnersLRLRVHealthNENew Leaf Venture Partners+3 more

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

TKTodd Kerkow(Co-Founder, President and CEO)inMJMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

Board seatASAmrinder SinghKirk Nielsen· per SEC Form D

Co-investorsHAHatteras Venture PartnersTRTreo Ventures, Llc

Overnight automated insulin delivery

Wilmington, US

JSJohn Sjolund(Chief Executive Officer of the Issuer)inJon Brilliant(Chief Financial Officer of the Issuer)

BoardPeter N. Townsend(Director)

Board seatJKJustin KleinASAmrinder Singh· per SEC Form D

Co-investorsSESerpentine Ventures

Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.

BiotechHealthtechMedical DevicesPlymouth, US

JEJAMES ERICKSON(Executive Officer)inMEMARTIN EMERSON(Executive Officer, Director)JSJohn Schellhorn(Executive Officer, Director, Promoter)inRobert K Davidson(Executive Officer)

BoardRERICHARD EMMITT(Director)inGregory Barrett(Director)

Board seatKirk NielsenBHBill Hoffman· per SEC Form D · $13.7M raise · filed Sep 2022

Co-investorsTHThe Vertical Group

Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters.

BiotechHardwareHealthtechMedical DevicesAliso Viejo, US

BJBrian J. Cox(Manager)inRhonda Robb(Executive Officer, Director)inRobert Rosenbluth(Director)

BoardDonald Milder(Director)JRJonathan Root(Director)inPaul Lubock(Director)

Board seatMKMike KramerKirk Nielsen· per SEC Form D

Co-investorsUSUS Venture PartnersGIGilde Healthcare

A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.

BiotechDigital HealthHealthtechMedical DevicesBaltimore, US

VVVictor Velculescu(Executive Officer, Director, Promoter)inLuis A. Diaz, Jr.(Executive Officer, Director, Promoter)SASam Angiuoli(Executive Officer)inSJSian Jones(Executive Officer)inLisa Kann(Executive Officer)inAnthony Newton(Executive Officer)

Board seatJKJustin Klein· per SEC Form D

Co-investors3B3B Future Health FundCACatalio Capital Management, LPCOCo-Win VenturesNENew Enterprise Associates (NEA)WIWindham Capital Partners

Rampart develops radiation shielding solutions for interventional medical procedures, offering lead-free protective equipment including ceiling-mounted shields, mobile barriers, and monitoring systems for interventional radiology and cardiology labs.

HealthtechMedical DevicesBirmingham, US

TLTom Livingston(Executive Officer, Director)inMichael Jackson(Executive Officer)Robert E. Foster, M.D.(Executive Officer, Director)

BoardChase Wise(Director)

Board seatMKMike KramerKirk Nielsen· per SEC Form D · $21.7M raise · filed May 2025

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.

Medical DevicesRedwood City, US

Alex DiNello(Executive Officer, Director)

BoardRichard Mott(Director)BABrent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)

Board seatJKJustin Klein· per SEC Form D

Co-investorsCACanaan PartnersEMEmergent Medical Partners, LLPLILightstone VenturesNENew Enterprise Associates (NEA)

Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility.

BiotechHealthtechMedical DevicesHouston, US

TKTim Keane(Founder)inASAlex Smith(Founder)inJeffrey Tyber(Director)SRStephen Ramon(Executive Officer)inTimothy J. Keane, Jr.(Executive Officer, Director)

BoardToby Hamilton(Director)

Board seatGBGreg Banker· per SEC Form D

Co-investorsASAsymmetry VenturesY Y CombinatorMUMutual Capital PartnersVEVentureSouq

BiotechSan Carlos, US

Surag Mantri(Executive Officer, Director)

BoardMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)in

Board seatJKJustin Klein· per SEC Form D

Co-investorsBOBoutique Venture PartnersLOLongitude CapitalNENeotribe Ventures

Apella provides real-time operating room monitoring and predictive analytics through computer vision and AI integration with EHR systems, helping surgical teams detect delays, optimize scheduling, and improve OR efficiency.

AI & Machine LearningDigital HealthHealthtech

Co-investorsK2K2 HealthVenturesLALayout VenturesOPOPAMP CAPITALTWTwine VenturesCACasdin CapitalHIHighlandX+2 more

Elucent Medical develops the EnVisio System, a surgical guidance platform that uses In-Body Spatial Intelligence and the SmartClip marker and SmartSensor to provide real-time 3D localization of tumors and target tissue.

HealthtechMedical Devices

Evident Vascular develops an intravascular ultrasound (IVUS) platform that uses AI for image interpretation and workflow improvements, aimed at peripheral vascular applications.

AI & Machine LearningHealthtechMedical Devices

Danielo Piazza(Founder)Howard Rosen(Founder)

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.

Digital HealthHardwareMedical DevicesDublin, IE

Co-investorsANAndera PartnersLILightstone VenturesLOLongitude CapitalNENew Enterprise Associates (NEA)GIGilde HealthcareGIGimv+5 more

Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis.

HardwareHealthtechMedical DevicesIrvine, US

WHWilliam H. Hoffman(Executive Officer, Director)inRobert Rosenbluth(Executive Officer, Director)

BoardDonald Milder(Director)KNKirk Nielsen(Director)inJRJonathan Root(Director)inBrian Cox(Director)

Co-investorsGIGilde HealthcareUSUS Venture PartnersVEVersant Ventures

BiotechHealthtechWayne, US

Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)

Co-investors41415 CapitalH.H.I.G. CapitalH.H.I.G. HealthBridge PartnersRURunway Growth CapitalH.H.I.G. BioHealth PartnersNENew Enterprise Associates (NEA)

Luna Connect offers a cloud-based SaaS platform for financial institutions such as banks, credit unions, and insurers to digitise customer engagement, automate lending, onboarding, ID verification, and compliance workflows using no-code automation and AI-driven analytics.

AI & Machine LearningFintechSaaSGalway, IE

BDBrian D'Arcy(Founder)in

Co-investorsHAHaymaker VenturesWIWinklevoss Capital

Luna develops a small patch pump with automated insulin dosing for insulin pen users to help manage glucose levels overnight.

Digital HealthHealthtechMedical Devices

JSJohn Sjölund(Founder)inSean Saint(Founder)inJon Brilliant(Founder)

Co-investorsSESerpentine VenturesWIWinklevoss CapitalINInterlock Capital

Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases.

BiotechHealthtechMedical Devices

Co-investorsSASanderling Ventures

Moxe operates a platform for the secure exchange of clinical data between healthcare payers and providers, transforming that data into usable formats to support payment and operations use cases.

Data & InfrastructureDigital HealthHealthtech

Madison, US

Daniel Wilson(Executive Officer, Director)

BoardGary J. Kurtzman, M.D.(Director)

Co-investorsAPApolloTRTrinity Capital

Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring.

BiotechHealthtechMedical DevicesCosta Mesa, US

Co-investorsBRBroadview VenturesGOGood Growth CapitalADAdvent Life Sciences

St.

HealthtechSt. Louis, US

SWScott Wrightstone(Executive Officer)inMaureen Oehler(Executive Officer)JPJason Pesterfield(Executive Officer, Director)inRDRyan Denney(Executive Officer)inMark Hunter(Executive Officer)inRobert Powers(Executive Officer)in

Co-investorsRCRC CapitalRERex Health VenturesADAdvantage Capital PartnersPRProlog VenturesVEVersant Ventures

Medical Devices

Co-investorsLILightstone Ventures